Sign inJoin waitlistJoin the waitlist

Elshad Hasanov

Assistant Professor, Department of Internal Medicine/Medical Oncology · Ohio State University Comprehensive Cancer Center – The James

Credentials: · · · · · ·

History

Ohio State University Comprehensive Cancer Center – The James
Present

MD Anderson
2023–2025
University of Texas M D Anderson Cancer Center
2020–2023
Internal Medicine
University of Texas Health Science Center at Houston
2016–2019
HACETTEPE UNIV, ANKARA
2008–2012

Research

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
The Lancet. Gastroenterology & hepatology · 2022 · 241 citations
Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL
Oncogene · 2017 · First of 9 authors · 43 citations
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
Review · Journal of Hepatocellular Carcinoma · 2021 · 38 citations

Eric Jonasch
17 papers
Nizar Tannir
10 papers
MH
Merve Hasanov
7 papers · 2 as a resident
Omar Alhalabi
6 papers · 2 as a fellow
Ahmed Kaseb
5 papers
Mehmet Bilen
5 papers
Pavlos Msaouel
5 papers · 3 as a resident
BY
Betul Gok Yavuz
4 papers · 2 as a fellow
SH
Sahin Hanalioglu
4 papers · 2 as a resident
YA
Yusuf Acikgoz
4 papers · 3 as a fellow
Amishi Shah
3 papers
Ashish Manne
3 papers · 1 as a fellow

Clinical trials

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
Site PI · Recruiting · Phase 2
Karie Runcie
2026–2028
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Site PI · Recruiting · Phase 1
Washington University School of Medicine
2025–2034